Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Inventory (2017 - 2025)

Dr Reddys Laboratories (RDY) has 8 years of Inventory data on record, last reported at $765.3 million in Q1 2024.

  • For Q1 2024, Inventory rose 29.25% year-over-year to $765.3 million; the TTM value through Mar 2024 reached $765.3 million, up 29.25%, while the annual FY2025 figure was $832.0 million, 8.37% up from the prior year.
  • Inventory reached $765.3 million in Q1 2024 per RDY's latest filing, up from $592.1 million in the prior quarter.
  • Across five years, Inventory topped out at $765.3 million in Q1 2024 and bottomed at $484.0 million in Q1 2020.
  • Average Inventory over 5 years is $628.2 million, with a median of $622.8 million recorded in 2021.
  • Peak YoY movement for Inventory: decreased 12.51% in 2023, then rose 29.25% in 2024.
  • A 5-year view of Inventory shows it stood at $484.0 million in 2020, then grew by 28.67% to $622.8 million in 2021, then rose by 8.65% to $676.7 million in 2022, then dropped by 12.51% to $592.1 million in 2023, then rose by 29.25% to $765.3 million in 2024.
  • Per Business Quant database, its latest 3 readings for Inventory were $765.3 million in Q1 2024, $592.1 million in Q1 2023, and $676.7 million in Q1 2022.